Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03064360 · ClinicalTrials.gov registry record
Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 200
- Enrollment target
NCT03064360: Completed study, sponsored by Cedars-Sinai Medical Center.
NCT03064360 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03064360 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Usual care may not identify subtle clinical changes that precede a major adverse cardiovascular event (MACE). Therefore investigators will explore the effectiveness of using biomarkers, patient reported outcomes (PROs), and patient reported informatics (PRIs) as predictors to a MACE event.
Primary Outcome
The outcome of interest for this study is MACE, which investigators define as a composite outcome of events including: death (all cause), non-fatal MI, non-fatal stroke, or hospitalization for heart failure. Investigators will generate subject-specific monthly summary scores for the PRI and PRO metrics. Analysis of PRO's, PRIs, and biomarker surrogates will be completed using Pearson correlations. To adjust for known risk markers of MACE, investigators will run linear regressions with levels of
Interventions
- OTHER Laboratory Biomarker Analysis
- BEHAVIORAL Questionnaires
- DEVICE Patient Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2020-01-01 |
What the finished NCT03064360 record still lists
NCT03064360 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03064360 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03064360 about?
NCT03064360 is a clinical study titled "Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring". Usual care may not identify subtle clinical changes that precede a major adverse cardiovascular event (MACE). Therefore investigators will explore the effectiveness of using biomarkers, patient reported outcomes (PROs), and patient reported informatics (PRIs) as predictors to a MACE event.
What is the current status of trial NCT03064360?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2017-02-13. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT03064360?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaires (BEHAVIORAL), Patient Activity (DEVICE).
Who is sponsoring clinical trial NCT03064360?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI